Literature DB >> 7393532

Mustardé flap lower lid reconstruction after malignancy.

M A Callahan, A Callahan.   

Abstract

The Mustardé rotational cheek flap has been used to reconstruct the lower eyelids of 55 patients since 1964. Results and complications were well-documented with preoperative and postoperative photographs, and the patients have been followed from one to 14 years with a mean age follow-up of seven years. The most frequent complications were downward contraction and sagging of the flap and ectropion of the lid margin. To prevent them, the zygomatico-cheek flap must be carefully designed, rotated, and sutured as high as possible so that immediately postoperatively, the palpebral fissure is only a narrow slit. The flap's lining should be of nasal septal mucosa and cartilage joined with permanent sutures to the medial and lateral canthal tendons.

Entities:  

Mesh:

Year:  1980        PMID: 7393532     DOI: 10.1016/s0161-6420(80)35237-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Eyelid Chemical Burns: A Multidisciplinary And Challenging Approach.

Authors:  C Keilani; A De Faria; A Baus; M Delbarre; J V Schaal; F Froussart-Maille; E Bey; P Duhamel
Journal:  Ann Burns Fire Disasters       Date:  2021-12-31

2.  Surgical outcomes of Tenzel rotational flap in upper and lower lid reconstruction without repair of posterior lamella: A modified approach.

Authors:  Salil Kumar Mandal; Anwesha Maitra; Purban Ganguly; Stuti Somani Agarwal
Journal:  Rom J Ophthalmol       Date:  2021 Oct-Dec

3.  The Use of Composite Flaps in the Management of Large Full-Thickness Defects of the Lower Eyelid.

Authors:  Shuo Fang; Chao Yang; Yuntong Zhang; Chunyu Xue; Hongda Bi; Haiying Dai; Xin Xing
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

4.  A Method to Reproduce Symmetry in Midfacial Reconstruction: A Report of 19 Cases.

Authors:  Xiaoli Lou; Chunyu Xue; Joseph A Molnar; Hongda Bi
Journal:  Adv Skin Wound Care       Date:  2020-07       Impact factor: 2.373

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.